Shop
Showing 337–352 of 370 results
-
Strategies for Minimizing Preclinical Testing: Meeting FDA Requirements without Breaking the Bank
$1,199.00 Add to cart -
Synthetic Data in Clinical Trials: FDA’s Current Stance on In Silico Evidence.
$199.00 Add to cart -
Synthetic Data in Clinical Trials: FDA’s Current Stance on In Silico Evidence.
$699.00 Add to cart -
Synthetic Data in Clinical Trials: FDA’s Current Stance on In Silico Evidence.
$1,199.00 Add to cart -
The 2026 SaMD Masterclass: Clinical Evidence Strategies and New FDA Enforcement Frontiers
$299.00 Add to cart -
The 2026 SaMD Masterclass: Clinical Evidence Strategies and New FDA Enforcement Frontiers
$999.00 Add to cart -
The Bayesian Shift: Implementing the 2026 FDA Guidance for Modern Clinical Trials
$199.00 Add to cart -
The Bayesian Shift: Implementing the 2026 FDA Guidance for Modern Clinical Trials
$699.00 Add to cart -
The Bayesian Shift: Implementing the 2026 FDA Guidance for Modern Clinical Trials
$1,199.00 Add to cart -
The R2 Revolution: Transforming CMC Summaries into Regulatory Assets
$199.00 Add to cart -
The R2 Revolution: Transforming CMC Summaries into Regulatory Assets
$699.00 Add to cart -
The R2 Revolution: Transforming CMC Summaries into Regulatory Assets
$1,199.00 Add to cart -
The Role of Adipose-Derived MSCs in Autism Spectrum Disorder: Neuroimmune Modulation and Clinical Evidence
$199.00 Add to cart -
The Role of Adipose-Derived MSCs in Autism Spectrum Disorder: Neuroimmune Modulation and Clinical Evidence
$699.00 Add to cart -
The Role of Adipose-Derived MSCs in Autism Spectrum Disorder: Neuroimmune Modulation and Clinical Evidence
$1,199.00 Add to cart -
Trial Master File (TMF): FDA Expectations from Sponsors and Sites
$199.00 Add to cart
